These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 20484426)

  • 41. Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.
    Thiagarajan A; Caria N; Schöder H; Iyer NG; Wolden S; Wong RJ; Sherman E; Fury MG; Lee N
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):220-7. PubMed ID: 22035663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.
    Trigonis I; Koh PK; Taylor B; Tamal M; Ryder D; Earl M; Anton-Rodriguez J; Haslett K; Young H; Faivre-Finn C; Blackhall F; Jackson A; Asselin MC
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):682-93. PubMed ID: 24504503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
    Bird D; Scarsbrook AF; Sykes J; Ramasamy S; Subesinghe M; Carey B; Wilson DJ; Roberts N; McDermott G; Karakaya E; Bayman E; Sen M; Speight R; Prestwich RJ
    BMC Cancer; 2015 Nov; 15():844. PubMed ID: 26530182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.
    Bradshaw TJ; Yip S; Jallow N; Forrest LJ; Jeraj R
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):399-405. PubMed ID: 24685446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adaptive dose painting by numbers for head-and-neck cancer.
    Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.
    Richard SD; Bencherif B; Edwards RP; Elishaev E; Krivak TC; Mountz JM; DeLoia JA
    Nucl Med Biol; 2011 May; 38(4):485-91. PubMed ID: 21531285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
    Pinkawa M; Holy R; Piroth MD; Klotz J; Nussen S; Krohn T; Mottaghy FM; Weibrecht M; Eble MJ
    Strahlenther Onkol; 2010 Nov; 186(11):600-6. PubMed ID: 20936457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
    J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.
    Nyflot MJ; Harari PM; Yip S; Perlman SB; Jeraj R
    Radiother Oncol; 2012 Oct; 105(1):36-40. PubMed ID: 23068711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
    Han DL; Jiang WR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):1-4. PubMed ID: 19538859
    [No Abstract]   [Full Text] [Related]  

  • 51. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
    Wang H; Vees H; Miralbell R; Wissmeyer M; Steiner C; Ratib O; Senthamizhchelvan S; Zaidi H
    Radiother Oncol; 2009 Nov; 93(2):220-5. PubMed ID: 19767115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET lesion segmentation using automated iso-intensity contouring in head and neck cancer.
    Simon E; Fox TH; Lee D; Waller AF; Pantalone P; Jani AB
    Technol Cancer Res Treat; 2009 Aug; 8(4):249-55. PubMed ID: 19645517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT.
    Studer G; Glanzmann C
    Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.
    McGuire SM; Menda Y; Boles Ponto LL; Gross B; Buatti J; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):888-93. PubMed ID: 21300484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.
    Wang YC; Hsieh TC; Yu CY; Yen KY; Chen SW; Yang SN; Chien CR; Hsu SM; Pan T; Kao CH; Liang JA
    J Radiat Res; 2012 Jul; 53(4):594-600. PubMed ID: 22843625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer.
    Pretz JL; Blake MA; Killoran JH; Mamon HJ; Wo JY; Zhu AX; Hong TS
    Pract Radiat Oncol; 2018; 8(3):179-184. PubMed ID: 29042120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of PET-CT based hypofractionated accelerated dose escalation in oropharyngeal cancers: Final dosimetric results of the VORTIGERN study. (Secondary endpoint of UK NCRI portfolio: MREC No: 08/H0907/127, UKCRN ID 7341).
    Chatterjee S; Kelly C; Arunsingh M; Chakrabarty C; Mott J
    J Cancer Res Ther; 2015; 11(2):391-6. PubMed ID: 26148606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatial Concordance of Tumor Proliferation and Accelerated Repopulation from Pathologic Images to 3'-[
    Li C; Zhang X; Pang L; Huang Y; Gao Y; Sun X; Yu J; Meng X
    Mol Imaging Biol; 2019 Aug; 21(4):713-721. PubMed ID: 30406513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a new visual uptake scoring scale for 18F-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions.
    Beauregard JM; Giraudet AL; Aide N; Hofman MS; Blum R; Drummond E; Roselt P; Hicks RJ
    Nucl Med Commun; 2013 Jun; 34(6):521-6. PubMed ID: 23542911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines.
    Bradshaw TJ; Bowen SR; Deveau MA; Kubicek L; White P; Bentzen SM; Chappell RJ; Forrest LJ; Jeraj R
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):787-95. PubMed ID: 25752393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.